A study co-authored by researchers from the University of Texas has found how certain cancers resist immunotherapy by preventing the immune system from activating. The team discovered that a key element of the immune system, NKG2A, cannot engage with cancer cells without a particular trigger, and the study’s findings could help develop more effective immunotherapy drugs.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
